NCT03880747

Brief Summary

There is no consensus on what type of function-preserving gastrectomy can provide the best patient quality of life (QOL). This study aims to evaluate the incidence of dumping syndrome after vagus nerve-preserving distal gastrectomy (VPNDG).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 9, 2017

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

March 17, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 19, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 19, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2020

Completed
Last Updated

March 9, 2021

Status Verified

March 1, 2021

Enrollment Period

2 years

First QC Date

March 17, 2019

Last Update Submit

March 7, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Dumping syndrome

    Sigstad score of equal or more than 7

    1 year

Secondary Outcomes (3)

  • EORTC C-30/STO22

    3 months, 6 months, 1 year

  • Postoperative complication

    3 months, 6 months, 1 year

  • Incidence of gallstones

    1 year

Other Outcomes (4)

  • Operative time

    Immediately after operation

  • Estimated blood loss

    Immediately after operation

  • Time to first flatus

    Within 1 week

  • +1 more other outcomes

Study Arms (1)

Vagus nerve preserving group

Patients who underwent vagus nerve-preserving distal gastrectomy for early gastric cancer

Procedure: Vagus nerve-preserving distal gastrectomy

Interventions

Laparoscopic distal gastrectomy with the preservation of the celiac and hepatic branch of the vagus nerve.

Vagus nerve preserving group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach

You may qualify if:

  • Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach planned to undergo laparoscopic vagus nerve-preserving distal gastrectomy

You may not qualify if:

  • Sacrificed vagus nerve
  • Anastomosis other than Roux-en Y gastrojejunostomy or uncut Roux-en Y gastrojejunostomy
  • conversion to an open procedure
  • combined resection of other organs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 13620, South Korea

Location

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 17, 2019

First Posted

March 19, 2019

Study Start

August 9, 2017

Primary Completion

August 19, 2019

Study Completion

August 20, 2020

Last Updated

March 9, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

There is currently no plan to share our IPD with other researchers unless needed.

Locations